awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26784482-2A3E5D0F-CC04-4D57-858A-AAC27FCC522C
Q26784482-2A3E5D0F-CC04-4D57-858A-AAC27FCC522C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784482-2A3E5D0F-CC04-4D57-858A-AAC27FCC522C
PCSK9 inhibition: the way forward in the treatment of dyslipidemia
P2860
Q26784482-2A3E5D0F-CC04-4D57-858A-AAC27FCC522C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26784482-2A3E5D0F-CC04-4D57-858A-AAC27FCC522C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
409ec086dddae5a2cb7743bcb110c903d411626b
P2860
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.